Table of Contents Chapter 1 Dendritic Cell Cancer Vaccine Market Overview 1.1 Dendritic Cell Cancer Vaccine Definition 1.2 Global Dendritic Cell Cancer Vaccine Market Size Status and Outlook (2016-2030) 1.3 Global Dendritic Cell Cancer Vaccine Market Size Comparison by Region (2016-2030) 1.4 Global Dendritic Cell Cancer Vaccine Market Size Comparison by Type (2016-2030) 1.5 Global Dendritic Cell Cancer Vaccine Market Size Comparison by Application (2016-2030) 1.6 Global Dendritic Cell Cancer Vaccine Market Size Comparison by Sales Channel (2016-2030) 1.7 Dendritic Cell Cancer Vaccine Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/Expansion) 1.7.4 COVID-19 Impacts 1.7.5 Post-Strategies of COVID-19 Chapter 2 Dendritic Cell Cancer Vaccine Market Segment Analysis by Player 2.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Player (2019-2021) 2.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Player (2019-2021) 2.3 Global Dendritic Cell Cancer Vaccine Average Price by Player (2019-2021) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Dendritic Cell Cancer Vaccine Market Segment Analysis by Type 3.1 Global Dendritic Cell Cancer Vaccine Market by Type 3.1.1 CreaVax 3.1.2 Sipuleucel-T (Provenge) 3.1.3 Others 3.2 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Type (2016-2021) 3.3 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2016-2021) 3.4 Global Dendritic Cell Cancer Vaccine Average Price by Type (2016-2021) 3.5 Leading Players of Dendritic Cell Cancer Vaccine by Type in 2021 3.6 Conclusion of Segment by Type Chapter 4 Dendritic Cell Cancer Vaccine Market Segment Analysis by Application 4.1 Global Dendritic Cell Cancer Vaccine Market by Application 4.1.1 Pediatrics 4.1.2 Adults 4.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Application (2016-2021) 4.3 Leading Consumers of Dendritic Cell Cancer Vaccine by Application in 2021 4.4 Conclusion of Segment by Application Chapter 5 Dendritic Cell Cancer Vaccine Market Segment Analysis by Sales Channel 5.1 Global Dendritic Cell Cancer Vaccine Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Sales Channel (2016-2021) 5.3 Leading Distributors/Dealers of Dendritic Cell Cancer Vaccine by Sales Channel in 2021 5.4 Conclusion of Segment by Sales Channel Chapter 6 Dendritic Cell Cancer Vaccine Market Segment Analysis by Region 6.1 Global Dendritic Cell Cancer Vaccine Market Size and CAGR by Region (2016-2030) 6.2 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Region (2016-2021) 6.3 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Region (2016-2021) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Dendritic Cell Cancer Vaccine Market Share by Type 6.4.3 North America Dendritic Cell Cancer Vaccine Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Dendritic Cell Cancer Vaccine Market Share by Type 6.5.3 Europe Dendritic Cell Cancer Vaccine Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Dendritic Cell Cancer Vaccine Market Share by Type 6.6.3 Asia-Pacific Dendritic Cell Cancer Vaccine Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Dendritic Cell Cancer Vaccine Market Share by Type 6.7.3 South America Dendritic Cell Cancer Vaccine Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Dendritic Cell Cancer Vaccine Market Share by Type 6.8.3 Middle East & Africa Dendritic Cell Cancer Vaccine Market Share by Application 6.8.4 UAE 6.8.5 Saudi Arabia 6.8.6 South Africa 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Dendritic Cell Cancer Vaccine Players 7.1 Medigene 7.1.1 Company Snapshot 7.1.2 Product/Service Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.2 Activarti 7.3 Argos Therapeutics 7.4 Batavia Bioservices 7.5 Bellicum Pharmaceuticals 7.6 Creagene 7.7 DanDrit Biotech 7.8 DCPrime 7.9 Sanpower (Dendreon) 7.10 Elios Therapeutics 7.11 Immunicum 7.12 Kiromic 7.13 Merck 7.14 Northwest Biotherapeutics 7.15 Glaxo Smith Kline 7.16 ImmunoCellular 7.17 Tella 7.18 Vaxil Bio 7.19 SOTIO 7.20 JW CreaGene 7.21 Immutep Limited 7.22 Dendreon Corporation 7.23 Oncobiomed Chapter 8 Upstream and Downstream Analysis of Dendritic Cell Cancer Vaccine 8.1 Industrial Chain of Dendritic Cell Cancer Vaccine 8.2 Upstream of Dendritic Cell Cancer Vaccine 8.3 Downstream of Dendritic Cell Cancer Vaccine Chapter 9 Development Trend of Dendritic Cell Cancer Vaccine (2022-2030) 9.1 Global Dendritic Cell Cancer Vaccine Market Size (Sales and Revenue) Forecast (2022-2030) 9.2 Global Dendritic Cell Cancer Vaccine Market Size and CAGR Forecast by Region (2022-2030) 9.3 Global Dendritic Cell Cancer Vaccine Market Size and CAGR Forecast by Type (2022-2030) 9.4 Global Dendritic Cell Cancer Vaccine Market Size and CAGR Forecast by Application (2022-2030) 9.5 Global Dendritic Cell Cancer Vaccine Market Size and CAGR Forecast by Sales Channel (2022-2030) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification

List of Tables and Figures Figure Dendritic Cell Cancer Vaccine Example Figure Global Dendritic Cell Cancer Vaccine Revenue (Million $) Status and Outlook (2016-2030) Figure Global Dendritic Cell Cancer Vaccine Revenue (Million $) Comparison by Region (2016-2030) Figure Global Dendritic Cell Cancer Vaccine Revenue (Million $) Comparison by Type (2016-2030) Figure Global Dendritic Cell Cancer Vaccine Revenue (Million $) Comparison by Application (2016-2030) Figure Global Dendritic Cell Cancer Vaccine Revenue (Million $) Comparison by Sales Channel (2016-2030) Table Global Dendritic Cell Cancer Vaccine Sales by Player (2019-2021) Table Global Dendritic Cell Cancer Vaccine Sales Market Share by Player (2019-2021) Figure Global Dendritic Cell Cancer Vaccine Sales Market Share by Player in 2021 Table Global Dendritic Cell Cancer Vaccine Revenue (Million $) by Player (2019-2021) Table Global Dendritic Cell Cancer Vaccine Revenue Market Share by Player (2019-2021) Figure Global Dendritic Cell Cancer Vaccine Revenue Market Share by Player in 2021 Table Global Dendritic Cell Cancer Vaccine Average Price by Player (2019-2021) Figure Global Dendritic Cell Cancer Vaccine Average Price by Player in 2021 Figure Global Dendritic Cell Cancer Vaccine Players Competition Situation – Top 5 Players’ Revenue Market Share in 2019 Figure Global Dendritic Cell Cancer Vaccine Players Competition Trends – Top 5 Players’ Revenue Market Share in 2021 Figure Example of CreaVax Figure Global CreaVax Revenue (Million $) and Growth Rate (2016-2021) Figure Example of Sipuleucel-T (Provenge) Figure Global Sipuleucel-T (Provenge) Revenue (Million $) and Growth Rate (2016-2021) Figure Example of Others Figure Global Others Revenue (Million $) and Growth Rate (2016-2021) Table Global Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) Table Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021) Figure Global Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2021 Table Global Dendritic Cell Cancer Vaccine Revenue (Million $) by Type (2016-2021) Table Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2016-2021) Figure Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type in 2021 Table Global Dendritic Cell Cancer Vaccine Average Price by Type (2016-2021) Figure Global Dendritic Cell Cancer Vaccine Average Price by Type in 2021 Table Leading Players of Dendritic Cell Cancer Vaccine by Type in 2021 Figure Example of Pediatrics Figure Global Dendritic Cell Cancer Vaccine for Pediatrics Revenue (Million $) and Growth Rate (2016-2021) Figure Example of Adults Figure Global Dendritic Cell Cancer Vaccine for Adults Revenue (Million $) and Growth Rate (2016-2021) Table Global Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) Table Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021) Figure Global Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2021 Table Leading Consumers of Dendritic Cell Cancer Vaccine by Application in 2021 Figure Example of Direct Channel Figure Global Dendritic Cell Cancer Vaccine for Direct Channel Revenue (Million $) and Growth Rate (2016-2021) Figure Example of Distribution Channel Figure Global Dendritic Cell Cancer Vaccine for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021) Table Global Dendritic Cell Cancer Vaccine Revenue by Sales Channel (2016-2021) Table Global Dendritic Cell Cancer Vaccine Revenue Market Share by Sales Channel (2016-2021) Figure Global Dendritic Cell Cancer Vaccine Revenue Market Share by Sales Channel in 2021 Table Leading Distributors/Dealers of Dendritic Cell Cancer Vaccine by Sales Channel in 2021 Table Global Dendritic Cell Cancer Vaccine Market Size and CAGR by Region (2016-2030) Table Global Dendritic Cell Cancer Vaccine Sales by Region (2016-2021) Table Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021) Figure Global Dendritic Cell Cancer Vaccine Sales Market Share by Region in 2021 Table Global Dendritic Cell Cancer Vaccine Revenue (Million $) by Region (2016-2021) Table Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2016-2021) Figure Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region in 2021 Table North America Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) Figure North America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021) Table North America Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) Figure North America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021) Figure North America Dendritic Cell Cancer Vaccine Market Share by Type in 2021 Figure North America Dendritic Cell Cancer Vaccine Market Share by Application in 2021 Figure United States Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure United States Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Canada Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Canada Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Mexico Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Mexico Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Table Europe Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) Figure Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021) Table Europe Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) Figure Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021) Figure Europe Dendritic Cell Cancer Vaccine Market Share by Type in 2021 Figure Europe Dendritic Cell Cancer Vaccine Market Share by Application in 2021 Figure Germany Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Germany Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure UK Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure UK Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure France Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure France Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Italy Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Italy Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Russia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Russia Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Spain Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Spain Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Table Asia-Pacific Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) Figure Asia-Pacific Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021) Table Asia-Pacific Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) Figure Asia-Pacific Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021) Figure Asia-Pacific Dendritic Cell Cancer Vaccine Market Share by Type in 2021 Figure Asia-Pacific Dendritic Cell Cancer Vaccine Market Share by Application in 2021 Figure China Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure China Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Japan Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Japan Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Korea Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Korea Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure India Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure India Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Southeast Asia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Southeast Asia Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Australia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Australia Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Table South America Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) Figure South America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021) Table South America Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) Figure South America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021) Figure South America Dendritic Cell Cancer Vaccine Market Share by Type in 2021 Figure South America Dendritic Cell Cancer Vaccine Market Share by Application in 2021 Figure Brazil Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Brazil Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Argentina Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Argentina Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Colombia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Colombia Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Table Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) Figure Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021) Table Middle East & Africa Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) Figure Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021) Figure Middle East & Africa Dendritic Cell Cancer Vaccine Market Share by Type in 2021 Figure Middle East & Africa Dendritic Cell Cancer Vaccine Market Share by Application in 2021 Figure UAE Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure UAE Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure Saudi Arabia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure Saudi Arabia Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Figure South Africa Dendritic Cell Cancer Vaccine Sales and Growth Rate (2016-2021) Figure South Africa Dendritic Cell Cancer Vaccine Revenue (Million $) and Growth Rate (2016-2021) Table Company Snapshot of Medigene Table Dendritic Cell Cancer Vaccine Introduction of Medigene Table Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share of Medigene (2019-2021) Table Industrial Chain of Dendritic Cell Cancer Vaccine Table Manufacturing Cost Structure of Dendritic Cell Cancer Vaccine Table General Manufacturing Process of Dendritic Cell Cancer Vaccine Table Leading Distributors/Dealers of Dendritic Cell Cancer Vaccine Table Leading Consumers of Dendritic Cell Cancer Vaccine Figure Global Dendritic Cell Cancer Vaccine Sales and Growth Rate Forecast (2022-2030) Figure Global Dendritic Cell Cancer Vaccine Revenue and Growth Rate Forecast (2022-2030) Table Global Dendritic Cell Cancer Vaccine Market Size and CAGR Forecast by Region (2022-2030) Table Global Dendritic Cell Cancer Vaccine Market Size and CAGR Forecast by Type (2022-2030) Table Global Dendritic Cell Cancer Vaccine Market Size and CAGR Forecast by Application (2022-2030) Table Global Dendritic Cell Cancer Vaccine Market Size and CAGR Forecast by Sales Channel (2022-2030)

Leading players of Dendritic Cell Cancer Vaccine including: Medigene Activarti Argos Therapeutics Batavia Bioservices Bellicum Pharmaceuticals Creagene DanDrit Biotech DCPrime Sanpower (Dendreon) Elios Therapeutics Immunicum Kiromic Merck Northwest Biotherapeutics Glaxo Smith Kline ImmunoCellular Tella Vaxil Bio SOTIO JW CreaGene Immutep Limited Dendreon Corporation Oncobiomed